This finding suggests that GR expression in tumoral cells and in nontransformed cells associated with tumors contributes to the biological function of breast cancer, and a detailed analysis of GC signaling could reveal genes that drive breast cancer and identify therapeutic targets [30]. The gene discussed is NR3C1; the disease is breast cancer.